Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LENZ Therapeutics, Inc. | Director | Stock Option (right to buy) | 27K | Mar 21, 2024 | Direct | ||
Nkarta, Inc. | Director | Stock Option (right to buy) | 22.5K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NKTX | Nkarta, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 1 | $0 | 4 | Mar 25, 2024 | Director |
LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 0 | $0 | 3 | Mar 25, 2024 | Director |
NKTX | Nkarta, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
NKTX | Nkarta, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
NKTX | Nkarta, Inc. | Jun 13, 2021 | 1 | $0 | 4 | Jun 15, 2021 | Director |